Haoran Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haoran Yang has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Jay K. Kolls
Departments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA
6 shared publications - Naoki Iwanaga
Department of Respiratory Medicine, Nagasaki University Hospital
4 shared publications Akhilesh Srivastava
Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, USA
2 shared publicationsElizabeth B. Norton
Department of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, USA
2 shared publications- Janet E. McCombs
Department of Medicine, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USA
2 shared publications - Joseph P. Hoffmann
Tulane University School of Medicine, New Orleans, LA, United States
2 shared publications
Latest Publications
- Open Access
- 9 April 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-12
Vaccine-elicited IL-1R signaling results in Th17 TRM-mediated immunity
Lung tissue resident memory (TRM) cells are thought to play crucial roles in lung host defense. We have recently shown that immunization with the adjuvant LTA1 (derived from the A1 domain of E. coli heat labile toxin) admixed with OmpX from K. pneumoniae can elicit antigen specific lung Th17 TRM cells that provide serotype independent immunity to members of the Enterobacteriaceae family. However, the upstream requirements to generate these cells are unclear. Single-cell RNA-seq showed that vaccine-elicited Th17 TRM cells expressed high levels of IL-1R1, suggesting that IL-1 family members may be critical to generate these cells. Using a combination of genetic and antibody neutralization approaches, we show that Th17 TRM cells can be generated independent of caspase-1 but are compromised when IL-1α is neutralized. Moreover IL-1α could serve as a molecular adjuvant to generate lung Th17 TRM cells independent of LTA1. Taken together, these data suggest that IL-1α plays a major role in vaccine-mediated lung Th17 TRM generation.
- 9 April 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-12
Open AccessVaccine-elicited IL-1R signaling results in Th17 TRM-mediated immunity
Lung tissue resident memory (TRM) cells are thought to play crucial roles in lung host defense. We have recently shown that immunization with the adjuvant LTA1 (derived from the A1 domain of E. coli heat labile toxin) admixed with OmpX from K. pneumoniae can elicit antigen specific lung Th17 TRM cells that provide serotype independent immunity to members of the Enterobacteriaceae family. However, the upstream requirements to generate these cells are unclear. Single-cell RNA-seq showed that vaccine-elicited Th17 TRM cells expressed high levels of IL-1R1, suggesting that IL-1 family members may be critical to generate these cells. Using a combination of genetic and antibody neutralization approaches, we show that Th17 TRM cells can be generated independent of caspase-1 but are compromised when IL-1α is neutralized. Moreover IL-1α could serve as a molecular adjuvant to generate lung Th17 TRM cells independent of LTA1. Taken together, these data suggest that IL-1α plays a major role in vaccine-mediated lung Th17 TRM generation.
- Open Access
- 1 March 2024
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 8 (3) , 242-253
Embigin Is Highly Expressed on CD4+ and CD8+ T Cells but Is Dispensable for Several T Cell Effector Responses
T cell immunity, including CD4+ and CD8+ T cell immunity, is critical to host immune responses to infection. Transcriptomic analyses of both CD4+ and CD8+ T cells of C57BL/6 mice show high expression the gene encoding embigin, Emb, which encodes a transmembrane glycoprotein. Moreover, we found that lung CD4+ Th17 tissue-resident memory T cells of C57BL/6 mice also express high levels of Emb. However, deletion of Emb in αβ T cells of C57BL/6 mice revealed that Emb is dispensable for thymic T cell development, generation of lung Th17 tissue-resident memory T cells, tissue-resident memory T cell homing to the lung, experimental autoimmune encephalitis, as well as clearance of pulmonary viral or fungal infection. Thus, based on this study, embigin appears to play a minor role if any in αβ T cell development or αβ T cell effector functions in C57BL/6 mice.
- 1 March 2024
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 8 (3) , 242-253
Open AccessEmbigin Is Highly Expressed on CD4+ and CD8+ T Cells but Is Dispensable for Several T Cell Effector Responses
T cell immunity, including CD4+ and CD8+ T cell immunity, is critical to host immune responses to infection. Transcriptomic analyses of both CD4+ and CD8+ T cells of C57BL/6 mice show high expression the gene encoding embigin, Emb, which encodes a transmembrane glycoprotein. Moreover, we found that lung CD4+ Th17 tissue-resident memory T cells of C57BL/6 mice also express high levels of Emb. However, deletion of Emb in αβ T cells of C57BL/6 mice revealed that Emb is dispensable for thymic T cell development, generation of lung Th17 tissue-resident memory T cells, tissue-resident memory T cell homing to the lung, experimental autoimmune encephalitis, as well as clearance of pulmonary viral or fungal infection. Thus, based on this study, embigin appears to play a minor role if any in αβ T cell development or αβ T cell effector functions in C57BL/6 mice.
- Open Access
- 21 June 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-15
MicroRNA-21 promotes pancreatic β cell function through modulating glucose uptake
Pancreatic β cell dysfunction contributes to the pathogenesis of type 2 diabetes. MiR-21 has been shown to be induced in the islets of glucose intolerant patients and type 2 diabetic mice. However, the role of miR-21 in the regulation of pancreatic β cell function remains largely elusive. In the current study, we identify the pathway by which miR-21 regulates glucose-stimulated insulin secretion utilizing mice lacking miR-21 in their β cells (miR-21βKO). We find that miR-21βKO mice develop glucose intolerance due to impaired glucose-stimulated insulin secretion. Mechanistic studies reveal that miR-21 enhances glucose uptake and subsequently promotes insulin secretion by up-regulating Glut2 expression in a miR-21-Pdcd4-AP-1 dependent pathway. Over-expression of Glut2 in knockout islets results in rescue of the impaired glucose-stimulated insulin secretion. Furthermore, we demonstrate that delivery of miR-21 into the pancreas of type 2 diabetic db/db male mice is able to promote Glut2 expression and reduce blood glucose level. Taking together, our results reveal that miR-21 in islet β cell promotes insulin secretion and support a role for miR-21 in the regulation of pancreatic β cell function in type 2 diabetes.
- 21 June 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-15
Open AccessMicroRNA-21 promotes pancreatic β cell function through modulating glucose uptake
Pancreatic β cell dysfunction contributes to the pathogenesis of type 2 diabetes. MiR-21 has been shown to be induced in the islets of glucose intolerant patients and type 2 diabetic mice. However, the role of miR-21 in the regulation of pancreatic β cell function remains largely elusive. In the current study, we identify the pathway by which miR-21 regulates glucose-stimulated insulin secretion utilizing mice lacking miR-21 in their β cells (miR-21βKO). We find that miR-21βKO mice develop glucose intolerance due to impaired glucose-stimulated insulin secretion. Mechanistic studies reveal that miR-21 enhances glucose uptake and subsequently promotes insulin secretion by up-regulating Glut2 expression in a miR-21-Pdcd4-AP-1 dependent pathway. Over-expression of Glut2 in knockout islets results in rescue of the impaired glucose-stimulated insulin secretion. Furthermore, we demonstrate that delivery of miR-21 into the pancreas of type 2 diabetic db/db male mice is able to promote Glut2 expression and reduce blood glucose level. Taking together, our results reveal that miR-21 in islet β cell promotes insulin secretion and support a role for miR-21 in the regulation of pancreatic β cell function in type 2 diabetes.
- 16 December 2021
- Published by H1 Connect
Faculty Opinions recommendation of MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function.
This paper revealed that the one-carbon (1C) metabolism enzyme methylenetetrahydrofolate dehydrogenase 2(MTHFD2) is a metabolic checkpoint in Th17 and Treg cells. MTHFD2 was critical to regulate de novo purine synthesis and signaling in activated CD4+ T cells. MTHFD2 deficiency resulted in decreased CD4+ cell proliferation, which was associated with aberrant FoxP3 expression and suppressive activity in Th17 cells, as well as enhanced Treg cell differentiation. MTHFD2 deficiency also downregulated mTORC1 signaling and altered DNA and histone methylation. Targeting MTHFD2 protected against multiple inflammatory disease models, including EAE, inflammatory bowel disease, and allergic airway disease. This finding indicates the potential of MTHFD2 serving as an anti-inflammatory target.
- 16 December 2021
- Published by H1 Connect
Faculty Opinions recommendation of MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function.
This paper revealed that the one-carbon (1C) metabolism enzyme methylenetetrahydrofolate dehydrogenase 2(MTHFD2) is a metabolic checkpoint in Th17 and Treg cells. MTHFD2 was critical to regulate de novo purine synthesis and signaling in activated CD4+ T cells. MTHFD2 deficiency resulted in decreased CD4+ cell proliferation, which was associated with aberrant FoxP3 expression and suppressive activity in Th17 cells, as well as enhanced Treg cell differentiation. MTHFD2 deficiency also downregulated mTORC1 signaling and altered DNA and histone methylation. Targeting MTHFD2 protected against multiple inflammatory disease models, including EAE, inflammatory bowel disease, and allergic airway disease. This finding indicates the potential of MTHFD2 serving as an anti-inflammatory target.
- 10 September 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 6 (63) , eabf1198
Vaccine-driven lung TRM cells provide immunity against Klebsiella via fibroblast IL-17R signaling
A subunit mucosal vaccine conferred protection against heterologous Klebsiella pneumoniae strains, via IL-17R signaling in lung fibroblasts.
- 10 September 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 6 (63) , eabf1198
Vaccine-driven lung TRM cells provide immunity against Klebsiella via fibroblast IL-17R signaling
A subunit mucosal vaccine conferred protection against heterologous Klebsiella pneumoniae strains, via IL-17R signaling in lung fibroblasts.
- 29 July 2021
- Published by H1 Connect
- Vol. 373 (6553)
Faculty Opinions recommendation of Enterically derived high-density lipoprotein restrains liver injury through the portal vein.
The biogenesis of high-density lipoprotein (HDL) requires apoA1 and the cholesterol transporter ABCA1. Although the liver generates most of the HDL in the blood, HDL synthesis also occurs in the small intestine. Here, we show that intestine-derived HDL traverses the portal vein in the HDL3 subspecies form, in complex with lipopolysaccharide (LPS)-binding protein (LBP). HDL3, but not HDL2 or low-density lipoprotein, prevented LPS binding to and inflammatory activation of liver macrophages and instead supported extracellular inactivation of LPS. In mouse models involving surgical, dietary, or alcoholic intestinal insult, loss of intestine-derived HDL worsened liver injury, whereas outcomes were improved by therapeutics that elevated and depended upon raising intestinal HDL. Thus, protection of the liver from injury in response to gut-derived LPS is a major function of intestinally synthesized HDL. Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
- 29 July 2021
- Published by H1 Connect
- Vol. 373 (6553)
Faculty Opinions recommendation of Enterically derived high-density lipoprotein restrains liver injury through the portal vein.
The biogenesis of high-density lipoprotein (HDL) requires apoA1 and the cholesterol transporter ABCA1. Although the liver generates most of the HDL in the blood, HDL synthesis also occurs in the small intestine. Here, we show that intestine-derived HDL traverses the portal vein in the HDL3 subspecies form, in complex with lipopolysaccharide (LPS)-binding protein (LBP). HDL3, but not HDL2 or low-density lipoprotein, prevented LPS binding to and inflammatory activation of liver macrophages and instead supported extracellular inactivation of LPS. In mouse models involving surgical, dietary, or alcoholic intestinal insult, loss of intestine-derived HDL worsened liver injury, whereas outcomes were improved by therapeutics that elevated and depended upon raising intestinal HDL. Thus, protection of the liver from injury in response to gut-derived LPS is a major function of intestinally synthesized HDL. Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.